SCHEMBL1667241

SCHEMBL1667241

O=C(Nc1ccc(Nc2ccc(Nc3ccc(N4CCC(O)CC4)cc3)cc2F)c(F)c1)c1ccc[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
GFER P55789 1/20 0.54
NTRK1 P04629 1/20 0.41
NTRK2 Q16620 1/20 0.41
MAPT P10636 4/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TNIK Q9UKE5 1/20 0.40
NAMPT P43490 1/20 0.39
KDM1A O60341 1/20 0.39
RCOR1 Q9UKL0 1/20 0.39
PDE7A Q13946 3/20 0.39
EGFR P00533 2/20 0.39
TMIGD3 P0DMS9 1/20 0.39
ADORA1 P30542 1/20 0.39
MALT1 Q9UDY8 1/20 0.38
TP53 P04637 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665013 0.97 NPC1 (0.55) NPC1RAB9AGFERNTRK1NTRK2
SCHEMBL1667245 0.94 NPC1 (0.54) NPC1RAB9AGFERNTRK1NTRK2
SCHEMBL1665017 0.93 NPC1 (0.55) NPC1RAB9AGFERNTRK1NTRK2
SCHEMBL1663562 0.93 NPC1 (0.55) NPC1RAB9AGFERNTRK1NTRK2
SCHEMBL1664967 0.87 NPC1 (0.71) NPC1RAB9AGFERMAPTMEN1
SCHEMBL6120725 0.85 RAB9A (0.51) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL1664099 0.84 NPC1 (0.41) NPC1RAB9ANTRK1NTRK2MAPT
SCHEMBL1664970 0.84 NPC1 (0.67) NPC1RAB9AGFERMAPTMEN1
SCHEMBL1664961 0.83 NPC1 (0.65) NPC1RAB9AGFERMAPTMEN1
SCHEMBL1664659 0.82 SETD2 (0.40) NPC1RAB9AGFERMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed